Christine L. Hann

Johns Hopkins University

Full Professor(heuristic)

Lung Cancer Research Studies · Oncology

h-index52

i10-index94

Publications506

Citations14,701

Grants

10 total · 0 active

NIH #3U01CA231776-05S1

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $368K
Period: 2018-09-03 → 2024-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5U01CA231776-05

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $599K
Period: 2018-09-03 → 2024-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #3U01CA231776-03S1

Tumor-barcoding coupled with high-throughput sequencing of a novel chemoradiation resistant SCLC mouse model

Amount: $154K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

10 total · 0 active

NIH #3U01CA231776-05S1

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $368K
Period: 2018-09-03 → 2024-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5U01CA231776-05

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $599K
Period: 2018-09-03 → 2024-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #3U01CA231776-03S1

Tumor-barcoding coupled with high-throughput sequencing of a novel chemoradiation resistant SCLC mouse model

Amount: $154K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5U01CA231776-04

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $598K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #3U01CA231776-04S1

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $368K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5U01CA231776-03

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $612K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5U01CA231776-02

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $593K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #1U01CA231776-01

Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC

Amount: $612K
Period: 2018-09-03 → 2023-08-31
PIs: 3
Est. capacity / PI: ~0 students

NIH #5R21CA188365-02

The role of the tumor suppressor RhoB in pulmonary aging and lung tumorigenesis

Amount: $176K
Period: 2015-04-01 → 2017-03-31
PIs: 1
Est. capacity / PI: ~0 students

NIH #1R21CA188365-01A1

The role of the tumor suppressor RhoB in pulmonary aging and lung tumorigenesis

Amount: $211K
Period: 2015-04-01 → 2017-03-31
PIs: 1
Est. capacity / PI: ~0 students

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0062

PageRank within Oncology co-authorship network

Explore collaboration map

Admission Signals

New paper: Table S5 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy2026-06-17

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0002-1467-5557

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 132

Table S5 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Figure S2 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Figure S9 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Figure S1 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors
2026-06-17
Table S1 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Table S2 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Data from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Figure S2 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Table S7 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Table S6 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Figure S5 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Supplementary Figure S7 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors
2026-06-17
Figure 1 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Supplementary Table S7 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Figure S12 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Table S2 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Figure S4 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Table S4 from Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non–Small Cell Lung Cancer
2026-06-17
Figure S7 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
2026-06-17
Supplementary Figure S3 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors
2026-06-17

Open author page on OpenAlex →